COVID-19 vaccine acceptance and associated factors among people living with HIV in the Middle East and North Africa region
Southern African Journal of HIV Medicine
| Field | Value | |
| Title | COVID-19 vaccine acceptance and associated factors among people living with HIV in the Middle East and North Africa region | |
| Creator | Mohamed, Rahma White, Trenton M. Lazarus, Jeffrey V. Salem, Amany Kaki, Reham Marrakchi, Wafa M Kheir, Sara G. Amer, Ibrahim M Ahmed, Fida A Khayat, Maie Al-Abdullah, Nabeela Ali, Batool Sultan, Roaa Alamri, Bandar Abdulmajid, Anouf Kooli, Ikbal Chakroun, Mohamed Madani, Tariq A. Esmat, Gamal Cordie, Ahmed | |
| Description | Background: Identifying coronavirus disease 2019 (COVID-19) vaccine acceptance and associated factors among people living with HIV (PLHIV) in the Middle East and North Africa region is important to meet the need for broad-scale vaccination against COVID-19.Objectives: To investigate the COVID-19 vaccine acceptance rate and factors among PLHIV in the Middle East and North Africa region.Method: An online cross-sectional survey was conducted among PLHIV currently living in Egypt, Tunisia and Saudi Arabia between March 2021 and August 2021.Results: Of the 540 respondents, 19.3% reported already being vaccinated against COVID-19 (n = 104), 32.0% responded ‘definitely yes’ (n = 173), and 13.3% responded ‘probably yes’ (n = 72) for intention to receive a COVID-19 vaccine, with an overall COVID-19 vaccine acceptance rate of 64.6% among PLHIV in the region. The most significant predictors of COVID-19 vaccine acceptance included feeling less worried about COVID-19 transmission post-vaccination (221.0% higher odds), and believing the disease is vaccine-preventable (160.0% higher odds). Reported barriers to COVID-19 vaccine acceptance include concerns about vaccine effectiveness and belief that HIV medications protect against COVID-19 transmission, living in a rural area and reporting less-frequent engagement with HIV care. Nine out of 10 participants reported that the chances of them getting COVID-19 vaccine would increase if given adequate information and if their doctor recommended it.Conclusion: Findings of the study can help researchers, health officials, and other health system actors understand the predictors and barriers to COVID-19 vaccine acceptance reported by PLHIV. This understanding could inform the future planning of interventions tailored to PLHIV. | |
| Publisher | AOSIS | |
| Date | 2022-08-24 | |
| Identifier | 10.4102/sajhivmed.v23i1.1391 | |
| Source | Southern African Journal of HIV Medicine; Vol 23, No 1 (2022); 9 pages 2078-6751 1608-9693 | |
| Language | eng | |
| Relation |
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:
https://sajhivmed.org.za/index.php/hivmed/article/view/1391/2834
https://sajhivmed.org.za/index.php/hivmed/article/view/1391/2835
https://sajhivmed.org.za/index.php/hivmed/article/view/1391/2836
https://sajhivmed.org.za/index.php/hivmed/article/view/1391/2838
https://sajhivmed.org.za/index.php/hivmed/article/view/1391/2837
|
|
ADVERTISEMENT
